01.01.2002 | Editorial
The Use of Placebo-Controlled and Non-inferiority Trials for the Evaluation of New Drugs in the Treatment of Postmenopausal Osteoporosis
Erschienen in: Osteoporosis International | Ausgabe 1/2002
Einloggen, um Zugang zu erhalten